Search PubMed⌕ Search

Biomedical subjects

C Niziak

Publications and source records attributed to C Niziak.

3 recordsLinked to original sources

Effect of deoxyribonucleic acid on the production of reduced oxygen by bleomycin and iron.

The binding of bleomycin to DNA in the presence and absence of ferric iron was measured by fluorescence spectroscopy. In millimolar concentrations of tris(hydroxymethyl)aminomethane, pH 7.5, approximately 80% of the bleomycin binds to DNA. Ferric iron seems to have no significant effect on the binding of DNA to bleomycin. The induction of oxygen uptake by ferrous iron and bleomycin was monitored in the presence and absence of DNA. DNA has no effect on the rate of oxygen uptake. Therefore, the iron binding site and the DNA binding site appear to be independent of each other. Under conditions where 80% of the bleomycin is bound to DNA, the ferrous iron-bleomycin-induced reduction of oxygen follows Michaelis-Menten kinetics. Ferrous iron autoxidation produces ethylene from methional. The addition of bleomycin greatly increases ethylene production. DNA, under conditions where 80% of the bleomycin is bound to DNA, inhibits ethylene production. Since ethylene is a measure of hydroxyl radical production, we conclude that DNA is able to compete with methional for the hydroxyl radical. We postulate a mechanism for DNA double-strand breaks in which the bleomycin selectively binds to DNA and recurrently produces the hydroxyl radical at that site. The localized generation of many hydroxyl radicals as provided by the proposed oxidation-reduction cycle mechanism may cause multiple strand breaks taking place on both strands of the DNA duplex leading to double-strand breaks. Since catalase, but not superoxide dismutase, is able to inhibit ferrous iron-bleomycin-induced products of the hydroxyl radical, hydrogen peroxide, but not the superoxide radical, is the immediate precursor of the hydroxyl radical.

Bleomycin↗

Intermediates in the ferrous oxidase cycle of bleomycin.

We have previously shown that the bleomycin-induced autooxidation of ferrous iron follows Michaelis--Menten kinetics which are characteristic of enzymatic reactions [Caspary, W. J., Lanzo, D. A., Niziak, C., Friedman, R., & Bachur, N. R. (1979) Mol. Pharmacol. 16, 256]. In this paper, we identify the iron complexes formed during this reaction. The first is a ferrous iron--bleomycin complex which can be considered the catalyst substrate complex. The product of this reaction is a ferric iron--bleomycin complex which is found in a low-spin and a high-spin form. The relative concentrations of these two forms are a function of pH. Glutathione, a biologically relevant reducing agent, binds to the ferric iron--bleomycin complex, reduces it, and may serve as a model for the reduction of the ferric iron--bleomycin complex to the ferrous state during the catalytic cycle. Oxygen uptake induced by bleomycin and ferrous iron is not inhibited by superoxide dismutase (SOD) or catalase. In the absence of bleomycin, catalase strongly inhibits oxygen uptake. This suggests the presence of a relatively stable intermediate in which the superoxide radical is not readily accessible to superoxide dismutase. At pH 9.3, we are able to observe a transient species by electron spin resonance (ESR). When potassium superoxide is added to the ferric iron--bleomycin complex, the same ESR spectrum is produced. We suggest that a transient species composed of a ferric iron, the superoxide ion, and bleomycin is formed. The precise nature of the binding cannot be determined from the data presented.

Bleomycin↗